Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Mesenchymal Stem Cell-Derived Exosomes for Covid-19 Therapy, Preclinical and Clinical Evidence Publisher



Kiaie N1, 2 ; Ghanavati SPM3 ; Miremadi SS4 ; Hadipour A5 ; Aghdam RM1
Authors

Source: International Journal of Stem Cells Published:2021


Abstract

Since the emergence of the novel coronavirus, named COVID-19, researchers are looking for a treatment to stop the evastating pandemic. During these efforts, mesenchymal stem cells (MSCs), the potential next generation of therapeutic methods with wide application for diseases, have successfully controlled cytokine storm following the virus infection. However, the use of MSCs has been limited due to the ethical issues, immunogenicity, and genetic modifications. Therefore, exosomes were introduced as a suitable substitute for the MSCs. In the case of COVID-19 treatment, both MSCs and several preclinical and clinical studies of exosomes for COVID-19 treatment. © 2021 by the Korean Society for Stem Cell Research
Other Related Docs